Liz Highleyman

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

Experts predict that more than a million people could die from liver cancer worldwide in 2040.

Adding an AKT inhibitor to fulvestrant doubled progression-free survival for patients with HR-positive, HER2-negative breast cancer.

Customized T-cell treatment is generally safe for people living with HIV, and outcomes are comparable to those of HIV-negative people.

The three-drug combination cured most people who had experienced previous treatment failure.

Advances in immunotherapy, new drug approvals and news about hard-to-treat cancers caught readers’ attention this year.

People who followed a protective diet and those on a standard hospital diet had a similar likelihood of infections.

Screening is recommended for current and former heavy smokers ages 50 to 80, but HIV-positive people may benefit from earlier screening.

A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.

Krazati led to tumor shrinkage in 43% of previously treated NSCLC patients with KRAS G12C mutations.

In September, the National Comprehensive Cancer Network (NCCN) released updated COVID vaccine recommendations.

An expert panel developed a set of evidence-based recommendations.

Liver cancer is often diagnosed late and it is among the fastest-rising causes of cancer death in the United States.

Patients treated with Trodelvy had a 21% reduction in the risk for death.

Routine screening can detect colorectal cancer at an early stage, when it’s easier to treat.